FDA Inspection 1325188 — Tara Seery, MD
The FDA completed an inspection of Tara Seery, MD on Jul 15, 2026 in El Segundo, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 15, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- El Segundo, CA (United States)
Additional Details
Sponsor-Investigator (S-I)